BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 4741936)

  • 1. Antitumor activity of N6-phenyladenosine, and inhibitor of adenosine utilization, in combination with related purine analogs.
    Grindey GB; Divekar AY; Hakala MT
    Cancer Res; 1973 Oct; 33(10):2459-63. PubMed ID: 4741936
    [No Abstract]   [Full Text] [Related]  

  • 2. Antitumor activity of a folate-cleaving enzyme, carboxypeptidase G 1 .
    Chabner BA; Chello PL; Bertino JR
    Cancer Res; 1972 Oct; 32(10):2114-9. PubMed ID: 5080761
    [No Abstract]   [Full Text] [Related]  

  • 3. Lack of activity of beta-2'-deoxythioguanosine against two tumors resistant to 6-thioguanine.
    Nelson JA; Kuhns JN; Carpenter JW
    Cancer Res; 1975 May; 35(5):1372-4. PubMed ID: 1168098
    [No Abstract]   [Full Text] [Related]  

  • 4. Experimental studies on the antitumor effect of ethidium bromide and related substances.
    Nishiwaki H; Miura M; Imai K; Ono R; Kawashima K
    Cancer Res; 1974 Oct; 34(10):2699-703. PubMed ID: 4413384
    [No Abstract]   [Full Text] [Related]  

  • 5. Enhancement of interferon antitumor action by sodium butyrate.
    Bourgeade MF; Cerutti I; Chany C
    Cancer Res; 1979 Nov; 39(11):4720-3. PubMed ID: 498098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening study on Taiwan plants for antitumor activities.
    King ML; Wang CT; Chang CF; Hsu HM; Wang SJ; Hartwell JL; Abbott BJ
    Cancer Chemother Rep 2; 1974 Jul; 4(3):1-96. PubMed ID: 4842546
    [No Abstract]   [Full Text] [Related]  

  • 7. 6-Mercaptopurine-induced potentiation of active immunotherapy in L1210-bearing mice treated with concanavalin A-bound leukemia cell vaccine.
    Kataoka T; Akahori Y; Sakurai Y
    Cancer Res; 1984 Feb; 44(2):519-24. PubMed ID: 6537896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antitumor chemotherapy. Considerations on the potential role of immunity].
    Mihich E
    Pathol Biol; 1967 Feb; 15(3):209-14. PubMed ID: 4860732
    [No Abstract]   [Full Text] [Related]  

  • 9. Influence of some sulfhydryl compounds on the antineoplastic effectiveness of 5-fluorouracil and 6-mercaptopurine.
    Danysz A; Wierzba K; Wutkiewicz M; Pniewska A; Pragłowski T; Burba-Anczewska I
    Arch Immunol Ther Exp (Warsz); 1984; 32(3):345-9. PubMed ID: 6395826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergism between the antiproliferative activities of arabinosyladenine and N6-benzyladenosine.
    Tritsch GL; Nechaev A; Mittelman A
    Cancer Biochem Biophys; 1977; 2(2):87-90. PubMed ID: 567524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical mechanisms for the synergism between 6-thioguanine and 6-(methylmercapto)purine ribonucleoside in sarcoma 180 cells.
    Nelson JA; Parks RE
    Cancer Res; 1972 Oct; 32(10):2034-41. PubMed ID: 4673141
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of the effects on cultured L1210 leukemia cells of the ribosyl, 2'-deoxyribosyl, and xylosyl homologs of tubercidin and adenosine alone or in combination with 2'-deoxycoformycin.
    Cass CE; Selner M; Tan TH; Muhs WH; Robins MJ
    Cancer Treat Rep; 1982 Feb; 66(2):317-26. PubMed ID: 6976834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Basis of observed resistance of L1210 leukemia in mice: methotrexate, 6-thioguanine, 6-methylmercaptopurine riboside, 6-mercaptopurine, 5-fluorouracil, and 1-beta-D-arabinofuranosylcytosine administered in different combinations.
    Kim K; Blechman WJ; Riddle VG; Pardee AB
    Cancer Res; 1981 Nov; 41(11 Pt 1):4529-34. PubMed ID: 7198006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of the antitumor effect of 6-mercaptopurine by vitamin A.
    Akiyama S; Masuda A; Tabuki T; Kuwano M; Komiyama S
    Gan; 1981 Oct; 72(5):742-6. PubMed ID: 7199007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methanesulfonates: the relationship of structure to antitumor activity.
    Sandberg JS; Wood HB; Engle RR; Venditti JM; Goldin A
    Cancer Chemother Rep 2; 1972 Nov; 3(1):137-229. PubMed ID: 4350012
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of drug combination of antitumor activity and myelotoxicity.
    Fujimoto S; Inouye T; Tsukagoshi S
    Gan; 1976 Apr; 67(2):207-14. PubMed ID: 964553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of antitumor effect of cyclophosphamide by thaliblastine in Lewis lung carcinoma and L1210 leukemia in mice.
    Stoychkov JN; Miloushev AS
    Biomedicine; 1980 Apr; 33(2):42-4. PubMed ID: 6447522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Studies on the antineoplastic action of N-methylisoindigotin].
    Ji XJ; Zhang FR; Liu Y; Gu QM
    Yao Xue Xue Bao; 1985 Apr; 20(4):247-51. PubMed ID: 4072694
    [No Abstract]   [Full Text] [Related]  

  • 19. Toxicological and antiproliferative effects of N6-(delta2-isopentenyl) adenosine, a natural component of mammalian transfer RNA.
    Suk D; Simpson CL; Mihich E
    Cancer Res; 1970 May; 30(5):1429-36. PubMed ID: 5426945
    [No Abstract]   [Full Text] [Related]  

  • 20. The synergistic anti-neoplastic activity of combinations of mitomycins with either 6-thioguanine or 5-fluorouracil.
    Sartorelli AC; Booth BA
    Cancer Res; 1965 Oct; 25(9):1393-400. PubMed ID: 5861069
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.